GLAXOSMITHKLINE PHARMACEUTICALS LTD,,,,,,,,,SCREENER.IN,
,,,,,,,,,,
Narration,Dec-08,Dec-09,Dec-10,Dec-11,Dec-12,Dec-13,Mar-15,Mar-16,Mar-17,Mar-18
Cash from Operating Activity, 319.42 , 503.30 , 467.55 , 321.56 , 293.63 , 267.42 , 340.88 , 138.27 , 232.28 , 474.77 
Cash from Investing Activity, 787.30 , 654.82 , 101.99 , 368.48 , (92.57), 197.98 , 177.62 , 499.09 , 303.08 , (107.01)
Cash from Financing Activity, (355.31), (391.77), (294.09), (391.82), (437.07), (490.08), (496.99), (638.33), (510.76), (306.63)
Net Cash Flow, 751.41 , 766.35 , 275.45 , 298.22 , (236.01), (24.68), 21.51 , (0.98), 24.59 , 61.12 
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
